GXE:ETR
Lakefront Biotherapeutics NV
€26.14
arrow_downward
-0.53%(-0.14) 1D
Oct 14, 5:35:46 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GXE...
Open
€25.98
High
€26.14
Low
€25.74
Mkt. cap
1.70B
Avg. vol.
572.00
Volume
574.00
P/E ratio
2.89
52-wk high
€30.02
52-wk low
€22.84
EPS
€9.05
No. of employees
196
Open
€25.98
High
€26.14
Low
€25.74
Mkt. cap
1.70B
Avg. vol.
572.00
Volume
574.00
P/E ratio
2.89
52-wk high
€30.02
52-wk low
€22.84
EPS
€9.05
No. of employees
196
News stories
From web sources and news partners
TradingView
·
46 minutes ago
S&P 500 ends longest streak of calm since 2020 as AI trade sinks
Traders Union
·
1 hour ago
Chris Ciovacco: S&P 500 hypothetical pullback to 200-day average would be 7.10%
The Motley Fool
·
39 minutes ago
The S&P 500 Has Risen 30.6% in the First 20 Months of Trump's Second Term, Just Ahead of the 28.5% Gain Over the Same Stretch of His First Term. Here's Why That Comparison Matters for Investors Heading Into the Midterms.
StoneX
·
7 hours ago
Dow Jones outlook: CPI, oil and yields put the rally to the test
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Websitelakefrontbio.com